Attenuated influenza virus construct with enhanced hemagglutinin protein expression
Jad Maamary1, Natalie Pica, Alan Belicha-Villanueva
1Department of Microbiology, Mount Sinai School of Medicine, New York, New York, USA.
Journal of Virology
|March 9, 2012
Summary
Altering the NS1 protein in influenza A viruses creates live attenuated vaccines. A novel mutation in the hemagglutinin (HA) gene enhances HA expression and improves vaccine efficacy in mice.
Area of Science:
- Virology
- Immunology
- Vaccine Development
Background:
- Live attenuated influenza vaccines (LAIVs) utilize NS1-truncated viruses for reduced virulence.
- NS1 truncation impairs viral protein expression, potentially limiting vaccine effectiveness.
- Hemagglutinin (HA) is the primary immunogen in influenza vaccines.
Purpose of the Study:
- To investigate the impact of NS1 truncation on HA protein expression in influenza A viruses.
- To enhance HA expression in NS1-truncated influenza viruses to improve vaccine efficacy.
- To identify strategies for restoring immunogen expression in attenuated viral vaccine platforms.
Main Methods:
- Recombinant H5N1 and H1N1 influenza viruses with truncated NS1 were generated.
- HA and nucleoprotein (NP) expression levels were quantified in infected cells.
- Mutations (G3A C8U) were introduced into the HA genomic RNA segment of an NS1-truncated virus.
- Mice were immunized with modified viruses and challenged with wild-type influenza.
Main Results:
- NS1-truncated viruses showed reduced HA protein and mRNA expression compared to wild-type.
- The reduction in HA expression was segment-specific and mapped to viral RNA termini.
- The G3A C8U mutations restored HA protein expression in NS1-truncated viruses.
- Mice vaccinated with the modified virus exhibited enhanced protection against wild-type influenza challenge.
Conclusions:
- NS1 truncation negatively impacts HA expression, a critical vaccine component.
- Introducing specific mutations in the HA RNA segment can restore expression levels.
- This strategy enhances the immunogenicity and protective efficacy of NS1-truncated influenza vaccines.
More Related Videos
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
10:39Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity
Published on: June 25, 2015
Related Concept Videos
01:27Influenza
Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...